Last reviewed · How we verify
NCT04249791: transplant
Laparoscopic-robotic Hysterectomy for Uterine Transplantation in Live-donor Patient.
NA trial testing Transplantation of the uterus from live donor. in Uterine Anomaly in 6 participants. Status unknown.
25 June 2020
Quick facts
| Lead sponsor | Barretos Cancer Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 6 |
| Start date | 25 June 2019 |
| Primary completion | 25 June 2020 |
| Estimated completion | 25 June 2021 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- Transplantation of the uterus from live donor.
Conditions studied
- Uterine Anomaly — all drugs for Uterine Anomaly →
Sponsor
Barretos Cancer Hospital
Who can join
Adults 18 to 65, female only, with Uterine Anomaly. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Currently, there is no standard and indicated standard access route for uterine removal in the uterine transplant donor patient. The aim of the study is to show the feasibility of performing this procedure by replicating in our center the results found in other recent studies and to try to reduce the surgery time for both the donor and recipient patients.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Uterine Transplantation with Robot-assisted Uterus Retrieval from Living Donor: First Case in Brazil.
Vieira MA, Souza C, Nobrega L, Reis R, et al · · 2021 · cited 7× · PMID 34487890 · DOI 10.1016/j.jmig.2021.08.028 -
Uterus Transplantation: Revisiting the Question of Deceased Donors versus Living Donors for Organ Procurement.
Frisch EH, Falcone T, Flyckt RL, Tzakis AG, et al · · 2022 · cited 6× · PMID 35956131 · DOI 10.3390/jcm11154516 -
Why uterine transplantation requires us to rethink the role of the pre-conception welfare principle.
O'Donovan L. · · 2022 · PMID 36237200 · DOI 10.1093/jlb/lsac028
Verify or expand the search:
- PubMed search for NCT04249791
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Barretos Cancer Hospital trials
Trials by the same sponsor.
- NCT06356012 — Clinical Outcome and Biomarkers for Predicting Immunological Response in Patients Treated with Imiquimod · Phase 4 · recruiting
- NCT05491395 — Hypofractionated Radiotherapy in Breast Cancer Patients With Prosthetic Reconstruction · NA · recruiting
- NCT05078528 — Low-cost Imaging Technology for Global Prevention of Cervical Cancer · NA · recruiting
- NCT06801405 — Antibiotic Prophylaxis in Percutaneous Nephrostomy Placements and Replacements for Malignant Urinary Tract Obstruction · completed
- NCT04025112 — Randomized Clinical Trial Comparing Rehabilitation Robotic Versus Conventional After Breast Cancer Surgery · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04249791 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Barretos Cancer Hospital
- Last refreshed: 31 January 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04249791.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing